Found 99 hits of Enzyme Inhibition Constant Data
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 96nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 320nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 430nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 520nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 620nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 630nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 680nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 770nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 790nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 830nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 890nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 920nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.24E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.28E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.47E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.69E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.83E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.84E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 2.07E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 2.13E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 2.42E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 2.49E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Sumitomo Pharmaceuticals Co., Ltd
Curated by ChEMBL
Affinity DataIC50: 2.58E+3nMAssay Description:Inhibitory concentration against Phosphodiesterase type 5More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)